FIIs and DIIs are piling into these four pharma stocks. Should you follow?

Before considering any of these stocks, you should examine the company’s revenue growth, profit margins, debt, valuations, R&D spending, and regulatory risks. Pharma companies may also face challenges from pricing pressure, regulatory interventions, and competition from generic drugs. Independent research, careful valuation and an assessment of personal risk tolerance are essential before making any investment decision.